Impact of French Medicines Agency's communication on sodium valproate prescription in women of childbearing potential age

A. Degremont (1) , B. Le Nautout (1) , C. Rault (2) , E. Oger (2) , A. Biraben (2, 3) , E. Polard (2) , E. Nowak (4, 5)

1 REPERES - Recherche en Pharmaco-épidémiologie et Recours aux Soins
2 Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Ponchaillou]
3 LTSI - Laboratoire Traitement du Signal et de l'Image
4 CHU - BREST - Hôpital de la Cavale Blanche - CHRU Brest
5 CIC Brest

Domaines: Ingénierie biomédicale

A. Degremont, B. Le Nautout, C. Rault, E. Oger, A. Biraben, et al.. Impact of French Medicines Agency's communication on sodium valproate prescription in women of childbearing potential age. Fundamental & Clinical Pharmacology, 2018, 32, pp.6-6. ⟨hal-01833091⟩